Biospecifics Technologies Corp Net Income per Employee (BSTC), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Biospecifics Technologies Corp  (NASDAQ: BSTC)
 

Biospecifics Technologies Net Income per Employee

BSTC's Quarterly Results, Trends, Rankings, Statistics
Biospecifics Technologies's Income per employee fell in the third quarter 2020 on a trailing twelve month basis to $ 542,345, but the productivity of Biospecifics Technologies's 32 employees remained above the company average.
The Healthcare sector has seen employees of 13 other companies achieving higher income per employee. While Biospecifics Technologies's total ranking has deteriorated compared to the previous quarter from 0 to 163.


What is Income per Employee Ratio?





Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BSTC Net Income per Employee (Sep 30 2020)
III. Quarter		 (Jun 30 2020)
II. Quarter		 (Mar 31 2020)
I. Quarter		 (Dec 31 2019)
IV. Quarter		 (Sep 30 2019)
III. Quarter
Y / Y Net Income Change -14.13 % -98.2 % 1.86 % 9.25 % 24.39 %
Net Income per Employee (TTM) $ 542,345 570,042 767,251 764,682 745,217
BSTC's Total Ranking # 163 # 0 # 0 # 0 # 0
Seq. Net Income Change 4551.81 % -97.43 % -38.82 % 17.23 % -2.39 %

BSTC Company Profile >> Back to BSTC Efficiency Comparisons >> Compare BSTC Net Income per Employee to its Competitors

BSTC Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 14
Healthcare Sector # 20
Overall Market # 163

Net Income per Employee Statistics
High Average Low
$ 767,251 $ 392,142 $ 132,392
(Mar 31 2020)   (Jun 30 2014)







Companies with similar Income per Employee for 12 month ending Sep 30 2020, within Healthcare Sector Income per Employee Income 12 month ending Sep 30 2020Number of Employees Sep 30 2020
Oramed Pharmaceuticals Inc  885,461.54 $ 11.511  Million 13 
Regen Biopharma Inc   701,423.33 $ 2.104  Million 3 
Biogen Inc   685,693.33 $ 5,142.700  Million 7,500 
Siga Technologies Inc  646,489.41 $ 31.678  Million 49 
Tenax Therapeutics Inc   613,331.62 $ 9.813  Million 16 
Horizon Therapeutics Public Limited Company  609,236.92 $ 792.008  Million 1,300 
Prestige Consumer Healthcare Inc   568,450.88 $ 324.017  Million 570 
Amgen Inc   565,538.46 $ 7,352.000  Million 13,000 
Blueprint Medicines Corporation  535,508.59 $ 311.666  Million 582 
Illumina Inc   498,437.50 $ 638.000  Million 1,280 
Acorda Therapeutics Inc   481,509.80 $ 49.114  Million 102 
Bio rad Laboratories Inc   472,570.60 $ 3,520.651  Million 7,450 
Seagen Inc   393,670.83 $ 472.405  Million 1,200 
Catalyst Pharmaceuticals Inc   392,722.98 $ 71.476  Million 182 
Semler Scientific inc   369,225.81 $ 11.446  Million 31 
Alpha Pro Tech Ltd   352,691.06 $ 43.381  Million 123 
Beyond Air Inc   349,443.50 $ 18.870  Million 54 
United Therapeutics Corporation  334,714.29 $ 468.600  Million 1,400 
Voyager Therapeutics Inc   284,347.52 $ 40.093  Million 141 


Date modified: 2026-08-29T17:26:02+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.